NCT04735900: lead-in FOLICOLOR Trial: Following Therapy Response Through Liquid Biopsy in Metastatic Colorectal Cancer Patients |
|
|
| Recruiting | N/A | 60 | Europe | Liquid biopsy sampling | University Hospital, Antwerp, Amgen | Metastatic Colorectal Cancer | 03/22 | 03/22 | | |
NCT04641676: A Study to Examine the Value of Broad Agnostic Next Generation Sequencing (NGS) Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Center |
|
|
| Recruiting | N/A | 1000 | Europe | NGS testing | The Belgian Society of Medical Oncology, Foundation Medicine, Sciensano, Roche Pharma AG | Metastatic Cancer, Local Tumor Invasion | 09/22 | 12/22 | | |
| Recruiting | N/A | 14 | Europe | Whole body hyperthermia, Standard of Care (SOC) chemotherapy according to the NCCN guidelines. | ElmediX | Advanced Cancer, Pancreatic Cancer Metastatic | 06/25 | 06/25 | | |
